Safety, tolerability, and pharmacokinetics of ibrexafungerp in healthy Chinese subjects: a randomized, double-blind, placebo-controlled phase 1 trial.
Journal Information
Full Title: Antimicrob Agents Chemother
Abbreviation: Antimicrob Agents Chemother
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Anti-Infective Agents
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Shuwen Yu and Benjie Wang have served as speakers for Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Qiong Wu, Chao Pan, Xiangqing Yu, and Yuhui Liu are the employees of Jiangsu Hansoh Pharmaceutical Group Co., Ltd, the sponsor of the study, at the time of this study. The remaining authors declare no conflict of interest."
"This study was funded by the Jiangsu Hansoh Pharmaceutical Group Co., Ltd."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025